Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report.
Streetwise Reports | May 14, 2020 |

Psyence Group: natural psychedelics for mental health and wellbeing

Our next company works to help people with a focus on natural psychedelics. Psyence Group uses natural psilocybin products to heal psychological trauma and to calm the mind during someone’s last stage of life while in palliative care. Here with us toda...
Brieanna McCutcheon | March 2, 2023 |

Revolutionizing Mental Health Treatment

(Click to play video.) Cybin Inc. ( NEO: CYBN , NYSE: CYBN , Forum ) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and...
Featured Submission | August 13, 2021 |

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. In an April 9 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Mesoblast Lt...
Streetwise Reports | April 16, 2020 |

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. In an April 4 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc.'s (INO:NASDA...
Streetwise Reports | April 11, 2019 |

Gold has immunity, silver has ratio

On Monday Wall Street pared back losses from last week’s sell-off, the worst since 2008, but it was only the promise of lowering interest rates, the return of the “punch bowl” hearkening back to recession-era stimulus, that has tempora...
Richard (Rick) Mills | March 3, 2020 |

From Cystic Fibrosis to COVID-19: A Medical Solution Like No Other

(Image via Dymedso Inc.) Airway clearance therapy has been a cornerstone of treatments aimed at minimizing the devastating effects of airway obstruction, infection, and inflammation caused by a buildup of mucus in lung conditions … but finding a non-invasive solutio...
Stockhouse Editorial | December 8, 2020 |

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus

Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. In a news release , Draganfly Inc. (DFLY:CSE; DFLYF:OTCQB) , which specializes in unmanned vehicle technology, announced it was chosen as the exclusive ...
Streetwise Reports | March 27, 2020 |

How Well are Cannabis Stocks Performing in the Market?

At this time last year, cannabis stock was considered to be the hottest investment trend on Wall Street as Canada lifted the veil of recreational marijuana, and it was legally approved for sale for adult-use, on Oct 2018. Investors were hoping legal weed sales would grow t...
Ved Prakash | November 12, 2019 |

PVH Shares Rise 20% on Sale of Speedo North America Business

Shares of PVH Corp. traded higher after the company reported that it had completed the sale of its Speedo North America business to the Pentland Group for $170 million in cash. Global apparel company PVH Corp. (PVH:NYSE) yesterday announced that it has "complet...
Streetwise Reports | April 8, 2020 |
1 2 3 4 5 6 7 8 9